Israel Englander I Mab Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in I Mab stock. As of the latest transaction made, Millennium Management LLC holds 11,325 shares of IMAB stock, worth $10,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,325

Previous 40,308 71.9%

Holding current value

$10,645

Previous $67,000 79.1%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.03 - $1.72 $29,852 - $49,850	-28,983 Reduced 71.9%	11,325 $14,000
Q2 2024 Aug 14, 2024	SELL	$1.58 - $1.9 $84,056 - $101,080	-53,200 Reduced 56.89%	40,308 $67,000
Q1 2024 May 15, 2024	SELL	$1.54 - $2.37 $150,601 - $231,769	-97,793 Reduced 51.12%	93,508 $173,000
Q4 2023 Feb 14, 2024	BUY	$1.21 - $1.9 $231,474 - $363,471	191,301 New	191,301 $363,000
Q1 2023 May 15, 2023	BUY	$3.08 - $7.39 $949,025 - $2.28 Million	308,125 Added 80.53%	690,767 $2.39 Million
Q4 2022 Feb 14, 2023	BUY	$3.22 - $4.86 $1.09 Million - $1.65 Million	338,675 Added 770.29%	382,642 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$4.01 - $12.34 $52,450 - $161,407	13,080 Added 42.35%	43,967 $176,000
Q2 2022 Aug 15, 2022	SELL	$8.27 - $18.43 $1.24 Million - $2.77 Million	-150,466 Reduced 82.97%	30,887 $349,000
Q1 2022 May 16, 2022	BUY	$12.54 - $46.93 $1.41 Million - $5.27 Million	112,374 Added 162.91%	181,353 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$45.28 - $74.5 $473,176 - $778,525	10,450 Added 17.85%	68,979 $3.27 Million
Q3 2021 Nov 15, 2021	BUY	$57.18 - $84.43 $1.87 Million - $2.76 Million	32,669 Added 126.33%	58,529 $4.24 Million
Q2 2021 Aug 16, 2021	SELL	$47.86 - $83.95 $14.6 Million - $25.5 Million	-304,036 Reduced 92.16%	25,860 $2.17 Million
Q1 2021 May 17, 2021	BUY	$44.38 - $63.97 $13.3 Million - $19.2 Million	299,397 Added 981.66%	329,896 $16 Million
Q4 2020 Feb 16, 2021	BUY	$32.94 - $47.15 $860,491 - $1.23 Million	26,123 Added 596.96%	30,499 $1.44 Million
Q3 2020 Nov 16, 2020	BUY	$27.46 - $47.03 $120,164 - $205,803	4,376 New	4,376 $206,000
Q2 2020 Aug 14, 2020	SELL	$13.0 - $31.0 $223,509 - $532,983	-17,193 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$10.63 - $15.37 $182,761 - $264,256	17,193 New	17,193 $224,000

Others Institutions Holding IMAB

# of Institutions

Shares Held

15.5M

Call Options Held

56.4K

Put Options Held

5.8K

View Full List

About I-Mab

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $78.1M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

More about IMAB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account